Advanced Filters
noise

One or multiple investigational sites, Spain Clinical Trials

A listing of One or multiple investigational sites, Spain clinical trials actively recruiting patients volunteers.

Found 64,772 clinical trials
L Laura Ruebush, PhD

Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein

The researchers overall objective is to determine whether plant and animal protein based proteins affect the anabolic responses across aging populations differently due to specific changes in the essential amino acids (EAA) and non-essential amino acids (NEAA) kinetic responses. The researchers central hypothesis is that a high EAA to NEAA …

50 - 95 years of age All Phase N/A
S Stephen Fletcher, DO

Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects

The purpose of this study is to determine the impact of an autologous umbilical cord patch for dural closure on the repair of open neural tube defect. The outcomes will evaluate successful defect closure, creation of a more capacious spinal canal, and reduction in inflammatory tissue response versus historical controls.

- 24 years of age All Phase N/A
A Ahmed M. Youssef, Lecturer

One Stage Ridge Splitting Using 2 Different Techniques in the Posterior Mandible

The selected patients will be informed of the nature of the research work and informed consent will be obtained. The control group ridge splitting with simultaneous implants using the conventional technique and study group ridge splitting with simultaneous implants using the piezo surgery. Pre operative procedures Patients of both groups …

20 - 48 years of age All Phase N/A
R Ryan Hughes, MD

M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

The purpose of this research study is to test the ability of a mobile device application (MyCap) to collect patient information about their radiation skin rash in patients with head and neck cancer being treated with radiation therapy.

18 years of age All Phase N/A

Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy

This is an Open Label, Phase IV, Post Authorisation Study to Evaluate the Efficacy, Safety and Immunogenicity of Daily Subcutaneous Metreleptin Treatment in people with Partial Lipodystrophy

12 years of age All Phase 4

Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)

The purpose of this study is to assess the preliminary efficacy of single SC administration of MBX 1416 at 2 dose levels in patients with PBH

18 - 65 years of age All Phase 2

Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE)

High Altitude Pulmonary Edema (HAPE) is a critical, non-cardiogenic pulmonary edema that manifests in high-altitude conditions, marked by the rapid onset of symptoms such as dyspnea, cough, frothy sputum, and cyanosis. It represents a significant cause of mortality among high-altitude illnesses due to its swift progression and elevated fatality rates …

18 - 65 years of age All Phase N/A
D Daniela Villani, PhD

Personalized Virtual Reality for Promoting Well-Being and Psychological Flexibility in General Practitioners

General Practitioners (GPs) face significant daily challenges, and promoting their well-being is essential. In particular, psychological flexibility (PF) is a key indicator of well-being. PF, conceptualized within Acceptance and Commitment Therapy (ACT), supports adaptation to change and fosters adaptive responses to demanding and complex situations. ACT identifies six core processes, …

18 years of age All Phase N/A
X Xue Yang, PhD

Chatbot Intervention to Reduce Common Digital Addictions, Sedentary Behaviors and Mental Distress Among Adolescents

The goal of the study is to investigate the efficacy of a secondary low-intensity stage of change (SoC) and motivational interviewing (MI)-based Chatbot-assisted intervention in reducing digital addictions in adolescents with Internet gaming disorder (IGD) and/or social media addiction (SMA) by conducting a RCT. Hypothesis: The intervention group will show …

10 - 19 years of age All Phase N/A
S Si-Yu Wang, Doctor

ctDNA-MRD Guided Consolidation Toripalimab in Stage IB-IIIA NSCLC

This study aims to incorporate circulating tumor DNA (ctDNA)-minimal residual disease (MRD) to personalize the administration of consolidation toripalimab therapy in resected stage IB-IIIA non-small-cell lung cancer (NSCLC) after adjuvant therapy. Toripalimab is a humanized monoclonal antibody for human programmed cell death protein 1. Toripalimab was approved as a consolidation …

18 - 75 years of age All Phase 2

Simplify language using AI